-
What is the Standard of Care For Multifocal Low-Grade Bladder Cancer? J. Urol. (IF 5.9) Pub Date : 2024-11-18 Eugene Pietzak,Christopher B Anderson
-
High 11-ketotestosterone linked to shorter time to castration resistance in recurrent non-metastatic prostate cancer. J. Urol. (IF 5.9) Pub Date : 2024-11-15 Cylia Dahmani,Patrick Caron,David Simonyan,Louis Lacombe,Armen Aprikian,Fred Saad,Michel Carmel,Simone Chevalier,Eric Lévesque,Chantal Guillemette
BACKGROUND. The contribution of 11-oxygenated androgens to the progression of lethal prostate cancer (PCa) remains unresolved. We hypothesized that evaluating circulating levels of 11-oxygenated androgens, such as the androgen receptor agonist 11-ketotestosterone (11KT), could serve as a potential predictor of the onset of castration resistant prostate cancer (CRPC). METHODS. We used mass spectrometry
-
Cuff Conundrums: Best Practice Recommendations for Urethral Instrumentation With an Artificial Urinary Sphincter in Place. J. Urol. (IF 5.9) Pub Date : 2024-11-13 Samuel J Ivan,Joshua A Cohn,Jeffrey C Loh-Doyle,Aaron C Lentz,Jay Simhan
-
Clinical and demographic factors linked to low-value emergency department visits in pediatric patients with spina bifida. J. Urol. (IF 5.9) Pub Date : 2024-11-12 Peter Y Cai,Erin R McNamara,Hatim Thaker,Carlos R Estrada,Hsin-Hsiao S Wang
PURPOSE Identifying factors associated with emergency visits that could be delivered at lower-cost sites may help guide population health strategies for pediatric patients with spina bifida. MATERIALS AND METHODS Emergency department encounters (2016-2023) by patients with spina bifida (< 18-years-old) in Pediatric Health Information System were identified. Absence of clinical and imaging charges was
-
Letter: Health Vulnerabilities of Spina Bifida Patients: Transition From Adolescents to Adults. J. Urol. (IF 5.9) Pub Date : 2024-11-11 Liangping Zhang
-
PD52-08 Adherence to Intracavernosal Injection Relative to Prescriber Choices and Patient Income: Erratum. J. Urol. (IF 5.9) Pub Date : 2024-11-08
-
Use and disuse of catheterizable channels as the primary method of emptying the neuropathic bladder: a single institutional cohort study. J. Urol. (IF 5.9) Pub Date : 2024-11-04 Yifan Meng Griffin,Rosalia Misseri,Joshua D Roth,Benjamin M Whittam,Pankaj Dangle,Shelly King,Kirstan K Meldrum,Martin Kaefer,Mark P Cain,Richard C Rink,Konrad M Szymanski
PURPOSE We aimed to assess long-term use of continent catheterizable urinary channels (CCCs) and explore potential risk factors for disuse. MATERIALS AND METHODS People undergoing appendicovesicostomy and Monti procedures at our institution were retrospectively reviewed (1991-2023). The main outcome was CCC disuse (not intermittently catheterizing channels as the primary method of bladder emptying)
-
Preoperative Immersive Virtual Reality (iVR) Applied to Percutaneous Nephrolithotomy: A Prospective Randomized Clinical Study of Surgical Planning and Clinical Outcomes. J. Urol. (IF 5.9) Pub Date : 2024-10-31 Andrei D Cumpanas,Mariah C Hernandez,Amanda McCormac,Marissa Ericson,Jaylen Lee,Jaime Altamirano-Villarroel,Candices M Tran,Zachary E Tano,Sohrab N Ali,Bruce M Gao,Pengbo Jiang,Roshan M Patel,Jaime Landman,Ralph V Clayman
PURPOSE Percutaneous nephrolithotomy (PCNL) is the procedure of choice for the management of complex or large renal stones. A major challenge for the surgeon, however, is the need to assimilate the nearly 2000 static images from a CT scan into a functional mental image to enable surgical planning. Accordingly, we investigated the potential of immersive virtual reality (iVR) to enhance surgical planning
-
Radiating for Two: Quantifying Radiation Exposure to Pregnant Urologists During Percutaneous Nephrolithotomy. J. Urol. (IF 5.9) Pub Date : 2024-10-31 Sikai Song,Akin S Amasyali,Daniel Jhang,Toby Clark,Kai Wen Cheng,Kyu Park,Nicole Mack,Cliff De Guzman,Ruby Kuang,Matthew Buell,Rose Leu,Kanha Shete,Ala'a Farkouh,Elizabeth A Baldwin,Evan Seibly,Zhamshid Okhunov,D Duane Baldwin
PURPOSE Current occupational recommendations limit fetal radiation dose to 1 mSv. With increased gender diversity in urology, understanding radiation exposure during pregnancy is crucial. The purpose of this study was to determine surgeon uterine radiation dose during percutaneous nephrolithotomy (PCNL) and compare effectiveness of several radiation reduction strategies in a cadaver model. MATERIALS
-
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle-Invasive Bladder Cancer. J. Urol. (IF 5.9) Pub Date : 2024-10-29 Eunice Villegas,Katherine Lajkosz,Shayan Din,Cynthia Kuk,Amy Chan,Jethro C C Kwong,Christian Vitug,Bruce Gao,Otto Hemminki,Dhiral Kot,Jimmy Misurka,Peter Black,Michael Jewett,Mark S Soloway,Morgan Roupret,Eva Compérat,Joan Sweet,Thomas Seisen,Neil E Fleshner,Jeffrey Wrana,Theodorus H van der Kwast,Girish S Kulkarni,Alexandre R Zlotta
PURPOSE Patients with Ta low-grade (LG) NMIBC rarely develop metastases or die of it. Long-term data are scant and length of follow-up poorly defined. MATERIALS AND METHODS This retrospective study included 521 patients diagnosed with primary TaLG NMIBC (n = 491) or papillary urothelial neoplasm of low malignant potential (n = 30) from 1989 to 2019 at an academic center. Patient data were acquired
-
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). J. Urol. (IF 5.9) Pub Date : 2024-10-24 Sandip M Prasad,Dimitar Shishkov,Nikola Vladimirov Mihaylov,Alexandre Khuskivadze,Pencho Genov,Vasyl Terzi,Max Kates,William C Huang,Michael J Louie,Sunil Raju,Brent Burger,Andrew Meads,Mark Schoenberg
PURPOSE To evaluate the efficacy and safety of UGN-102 chemoablation for the primary treatment of patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer. MATERIALS AND METHODS ENVISION is an ongoing, multinational, single-arm, Phase 3 study in patients with a biopsy-proven recurrence of untreated low-grade intermediate-risk nonmuscle-invasive bladder cancer. Patients
-
Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial. J. Urol. (IF 5.9) Pub Date : 2024-10-23 David Staskin,Janet Owens-Grillo,Elizabeth Thomas,Eric Rovner
-
-
Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. J. Urol. (IF 5.9) Pub Date : 2024-10-18 Tarek Benzouak,Abdulmalik Addar,Michael A Prudencio-Brunello,Ammar Saed Aldien,Steve E Amougou,Ahmad AlShammari,Mohammed Ramadhan,Serge Carrier,Mélanie Aubé-Peterkin,Fadl Hamouche
PURPOSE As the prevalence of benign prostatic hyperplasia (BPH) increases, the demand for surgical interventions that optimize patient outcomes while minimizing complications grows. This systematic review compares the efficacy, efficiency, and safety of holmium laser enucleation of the prostate (HoLEP) with robotic-assisted simple prostatectomy (RASP), providing insights for evidence-based surgical
-
Clinical Factors Associated With Suspicious 18F-DCFPyL PSMA PET Activity in Patients Initially Managed With Radical Prostatectomy Including Prostate-Specific Antigen < 0.5 ng/mL. J. Urol. (IF 5.9) Pub Date : 2024-10-18 Eric V Li,Richard Bennett,Austin Ho,Clarissa Wong,Ashorne K Mahenthiran,Sai Kaushik Shankar Ramesh Kumar,Zequn Sun,Hatice Savas,Steven P Rowe,Edward M Schaeffer,Hiten D Patel,Ashley Ross
PURPOSE There are limited data on PSMA PET/CT for workup of recurrence after radical prostatectomy (RP) at low PSA values. We evaluated a PSMA PET/CT cohort of patients with post-RP, focusing on patients with PSA < 0.5 ng/mL. MATERIALS AND METHODS We identified a retrospective cohort who underwent piflufolastat F-18 PSMA PET/CT across an 11 hospital system from July 2021 to February 2023. Prostate-specific
-
From Error to Excellence: An Evolving Paradigm for Improving the Diagnostic Process. J. Urol. (IF 5.9) Pub Date : 2024-10-16 Karen E Johnson,David F Friedlander,Matthew E Nielsen
-
Can We Be Less Active in Prostate Cancer Surveillance? J. Urol. (IF 5.9) Pub Date : 2024-10-16 Miko Filon,Brock O'Neil
-
Letter: The Extraperitoneal Midline Approach: A Game Changer to Access the Retroperitoneum? J. Urol. (IF 5.9) Pub Date : 2024-10-16 Christian Daniel Fankhauser,Silvan Sigg,Nirmish Singla
-
Letter: Enhancing Patient-Centered Communication in Endourologic Research: A Call for Adoption of ASCO's Language of Respect Guidelines. J. Urol. (IF 5.9) Pub Date : 2024-10-16 Jonathan Alcantar,Brandon Piyevsky,Mohammed Shahait,Ryan W Dobbs
-
Artificial Urinary Sphincter Implants in Men: A National Health Care Data System-Based Study to Assess Reinterventions in France. J. Urol. (IF 5.9) Pub Date : 2024-10-14 Louis Lenfant,Yoann Taillé,Emmanuel Chartier-Kastler,Bertrand Lukacs,Thomas Seisen,Morgan Roupret,Aurélien Beaugerie,Eric Vicaut,Pierre C Mozer
PURPOSE Significant concerns remain regarding the long-term outcomes of AMS 800 artificial urinary sphincter (AUS) implants in men. The objective was to assess the long-term AUS reintervention (replacement or removal) rates after a first-ever AUS implantation. MATERIALS AND METHODS This population-based retrospective cohort study included all men age ≥ 18 years in France who underwent a first-ever
-
Furthering the Capacity of Urologists to Shape the Field of Dissemination and Implementation Science and Enhance Clinical Practice. J. Urol. (IF 5.9) Pub Date : 2024-10-14 Shellie D Ellis,Ted A Skolarus
-
Artificial Intelligence-Based Assessment of Preoperative Body Composition is Associated With Early Complications After Radical Cystectomy. J. Urol. (IF 5.9) Pub Date : 2024-10-11 Vidit Sharma,Anthony Fadel,Matthew K Tollefson,Sarah P Psutka,Daniel J Blezek,Igor Frank,Prabin Thapa,Robert Tarrell,Lyndsay D Viers,Aaron M Potretzke,Robert P Hartman,Stephen A Boorjian,Boyd R Viers
PURPOSE We aimed to use a validated artificial intelligence (AI) algorithm to extract muscle and adipose areas from CT images before radical cystectomy (RCx) and then correlate these measures with 90-day post-RCx complications. MATERIALS AND METHODS A tertiary referral center's cystectomy registry was queried for patients who underwent RCx between 2009 and 2017 for bladder cancer. Eight hundred forty-three
-
Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J. Urol. (IF 5.9) Pub Date : 2024-10-09 Mary O Fakunle,Janet E Cowan,Samuel L Washington,Katsuto Shinohara,Hao G Nguyen,Peter R Carroll
PURPOSE Serial biopsy is a mainstay for patients on active surveillance (AS) for prostate cancer. mpMRI targeting has become a standard. It is unclear whether targeted biopsy alone reliably identifies the dominant lesion, thereby obviating the need for systematic sampling. MATERIALS AND METHODS Participants enrolled in AS with early-stage prostate cancer (PSA < 20, cT1-2, GG1-2) and underwent 2+ systematic
-
Predicting Response to Intravesical BCG in High-Risk NMIBC Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort. J. Urol. (IF 5.9) Pub Date : 2024-10-09 Yair Lotan,Viswesh Krishna,Waleed M Abuzeid,Bryn Launer,Sam S Chang,Vrishab Krishna,Siddhant Shingi,Jennifer B Gordetsky,Thomas Gerald,Solomon Woldu,Eugene Shkolyar,Dickon Hayne,Andrew Redfern,Lisa Spalding,Courtney Stewart,Eduardo Eyzaguirre,Shamsunnahar Imtiaz,Vikram M Narayan,Vignesh T Packiam,Michael A O'Donnell,Roger Li,Loic Baekelandt,Steven Joniau,Tahlita Zuiverloon,Mario I Fernandez,Marcela
PURPOSE There are few markers to identify those likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG). We developed and validated artificial intelligence-based histologic assays that extract interpretable features from transurethral resection of bladder tumor digitized pathology images to predict risk of recurrence, progression, development of BCG-unresponsive
-
MP75-10 Nocturia Across the Heart Failure Continuum: Results From an Outpatient Urology Population: Erratum. J. Urol. (IF 5.9) Pub Date : 2024-10-09
-
-
Higher Morbidity and Mortality in Women With Fournier Gangrene Compared With Men: Insights From National Inpatient Sample Data. J. Urol. (IF 5.9) Pub Date : 2024-10-02 Behzad Abbasi,Emily Hacker,Umar Ghaffar,Nizar Hakam,Kevin D Li,Sultan Alazzawi,Adrian Fernandez,Hiren V Patel,Benjamin N Breyer
PURPOSE To compare Fournier gangrene in female and male patients and identify mortality-associated characteristics in both. MATERIALS AND METHODS We used National Inpatient Sample data (2016-2020) to identify Fournier gangrene cases and extracted demographic, comorbidity, and procedural variables. Multivariable regression models were used to identify mortality risk factors for both cohorts. RESULTS
-
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI? J. Urol. (IF 5.9) Pub Date : 2024-10-02 Yasin Bhanji,Mufaddal K Mamawala,Sean A Fletcher,Patricia Landis,Hiten D Patel,Katarzyna J Macura,Christian P Pavlovich
PURPOSE Men diagnosed with prostate cancer (PCa) considering active surveillance (AS) are recommended confirmatory biopsy (CBx). Whether this is necessary in the era of MRI-informed biopsies is questionable. MATERIALS AND METHODS We studied men with grade group (GG) 1 PCa at diagnostic biopsy (DBx) considering AS who underwent MRI and CBx (systematic + targeted) within 18 months. Outcomes were grade
-
An Automated Electronic Health Record Score to Estimate Length of Stay and Readmission in Patients Undergoing Radical Cystectomy for Bladder Cancer. J. Urol. (IF 5.9) Pub Date : 2024-10-02 Simon John Christoph Soerensen,Bogdana Schmidt,I-Chun Thomas,Maria E Montez-Rath,Alan E Thong,Kris Prado,Jay B Shah,Eila C Skinner,John T Leppert
PURPOSE Patients treated with radical cystectomy experience a high rate of postoperative complications and frequent hospital readmissions. We sought to explore the utility of the Care Assessment Need (CAN) score, derived from electronic health data, to estimate the risk of these adverse clinical outcomes, thereby aiding patient counseling and informed treatment decision-making. MATERIALS AND METHODS
-
Impact of Either Trendelenburg or Reverse Trendelenburg Positioning for Ureteroscopy Lithotripsy Procedures: A Systematic Review and Meta-Analysis. J. Urol. (IF 5.9) Pub Date : 2024-09-30 Henrique L Lepine,Fabio C Vicentini,Wilson R Molina,Carolina M Llata,Giovanni S Marchini,Fabio C M Torricelli,Carlos A Batagello,Alexandre Danilovic,William C Nahas,Eduardo Mazzucchi
PURPOSE Urologists encounter multiple challenges in managing ureteral stones with ureteroscopic laser lithotripsy. This meta-analysis assesses the effectiveness of alternative surgical positioning, Reverse Trendelenburg (RevTren) and Trendelenburg (Tren), in reducing stone migration and enhancing outcomes compared with standard dorsal lithotomy positioning. MATERIALS AND METHODS A systematic review
-
Testosterone Therapy in Men After Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer. J. Urol. (IF 5.9) Pub Date : 2024-09-30 Jose M Flores,Emily A Vertosick,Carolyn A Salter,Nicole Benfante,Patrick Teloken,Boback Berookhim,Lawrence Jenkins,Sigrid Carlsson,Vincent Laudone,James Eastham,Andrew J Vickers,John P Mulhall
PURPOSE Testosterone therapy (TTh) in men with T deficiency who have undergone radical prostatectomy (RP) for prostate cancer remains controversial. We aimed to assess the impact of TTh on biochemical recurrence (BCR) rates after RP in men with low-intermediate organ-confined disease. MATERIALS AND METHODS This study included men who underwent an RP at our institution for organ-confined prostate cancer
-
Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer. J. Urol. (IF 5.9) Pub Date : 2024-09-30 Benjamin V Stone,Christine A Dominas,Sharath K Bhagavatula,Sebastian W Ahn,Zuzana Tatarova,Juraj Jakubik,Destiny Matthew,Matthew Mossanen,Daniella Furtado,Kemal Tuncali,Nobuhiko Hata,Clare Tempany,Oliver Jonas,Adam S Kibel
PURPOSE The purpose of this study was to assess safety and feasibility of percutaneous MR-guided placement of an implantable microdevice (IMD) to evaluate in situ intratumor response to multiple pharmacologic agents in men with intermediate-risk and high-risk localized prostate cancer. MATERIALS AND METHODS Biocompatible IMDs measuring 750 µm in diameter and 5 mm in length were prepared with 20 reservoirs
-
Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors. J. Urol. (IF 5.9) Pub Date : 2024-09-30 Kshitij Pandit,Paul Riviere,Kylie Morgan,Tyler Nelson,Margaret Meagher,Dhruv Puri,Nuphat Yodkhunnatham,Leah Deshler,Elizabeth Duran,Daniel Sabater-Minarim,Juan Javier-Desloges,Amir Salmasi,Rana R McKay,Frederick Millard,Tung-Chin Hsieh,Darshan P Patel,Brent S Rose,Aditya Bagrodia
PURPOSE The aim of this project was to characterize the incidence of men's health disorders, specifically focusing on the incidence of erectile dysfunction (ED) and testosterone deficiency (TD) in a large, nationwide study of testicular cancer (TC) survivors treated in a centralized health care system. PATIENTS AND METHODS We conducted a retrospective cohort study of US veterans diagnosed with TC from
-
A Patient-Prioritized Research Agenda for Clinical Trials in Kidney Stone Disease. J. Urol. (IF 5.9) Pub Date : 2024-09-20 Jonathan S Ellison,Kathryn E Flynn,Katherine Sheridan,Samantha Siodlarz,Jodi Antonelli,Christopher E Bayne,Hunter Beck,Christina Ching,Pankaj P Dangle,Casey Dauw,Carley Davis,Kim Hollander,Dirk Lange,Kristi Ouimet,Carswell Ouimet,Amy Y Pan,Kristina Penniston,Charles D Scales,Nayan Shah,Ryan Spiardi,Necole Streeper,Kristin Whitmore,Mike Witt,Liyun Zhang,Gregory E Tasian
PURPOSE To ensure that research on kidney stones provides meaningful impact for the kidney stone community, patients and caregivers should be engaged as stakeholders in clinical trial design, starting at study inception. This project aimed to elicit, refine, and prioritize research ideas from kidney stone stakeholders to develop a patient-centered research agenda for clinical trials. MATERIALS AND
-
Reevaluating the Definition of "Clinically Significant" Prostate Cancer as Grade Groups 2-5: An Imperative for Improved Risk Stratification. J. Urol. (IF 5.9) Pub Date : 2024-09-17 Sigrid V Carlsson,Peter R Carroll,Freddie C Hamdy
-
Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. J. Urol. (IF 5.9) Pub Date : 2024-09-17 Klaus-Peter Dieckmann,Gazanfer Belge
-
Technical Considerations to Minimize False-Positive Findings in Blue Light Cystoscopy for Nonmuscle-Invasive Bladder Cancer. J. Urol. (IF 5.9) Pub Date : 2024-09-16 Alireza Ghoreifi,Siamak Daneshmand
-
Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors. J. Urol. (IF 5.9) Pub Date : 2024-09-13 Muhannad Alsyouf,Alireza Ghoreifi,Arman Ashrafi,Seyedeh-Sanam Ladi-Seyedian,Hamed Ahmadi,Madeleine Burg,Antoin Douglawi,Qi Nie,Ming Li,Sumeet Bhanvadia,Anne Schuckman,Hooman Djaladat,Siamak Daneshmand
PURPOSE A midline extraperitoneal approach for retroperitoneal lymph node dissection (EP-RPLND) has been associated with decreased morbidity compared to the transperitoneal approach. We aimed to review our 11-year experience in patients with germ cell tumors (GCTs) who underwent EP-RPLND at a single institution. MATERIALS AND METHODS All patients with GCT who underwent EP-RPLND between 2010 and 2021
-
Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial. J. Urol. (IF 5.9) Pub Date : 2024-09-10 Ben H Chew,Jonathan D Harper,Roger L Sur,Thomas Chi,Shubha De,Anne R Buckley,Ryan F Paterson,Victor K F Wong,Connor M Forbes,M Kennedy Hall,Ross Kessler,Seth K Bechis,Jason R Woo,Ralph C Wang,David B Bayne,Derek Bochinski,Trevor D Schuler,Tim A Wollin,Rahim Samji,Mathew D Sorensen
PURPOSE This study reports on a prospective, multicenter, single-arm, clinical trial utilizing the SonoMotion (San Mateo, California) Break Wave lithotripsy (BWL) device to fragment urinary stones. MATERIALS AND METHODS Patients with a urinary stone underwent a single treatment of 30 minutes and peak negative pressure of 4.5 to 8 MPa. Subjects were contacted and outcomes assessed at 7, 14, and 35 days
-
Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J. Urol. (IF 5.9) Pub Date : 2024-09-10 Mattia Longoni,Giuseppe Rosiello,Alessandro Larcher,Francesco Montorsi,Umberto Capitanio
-
Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK. J. Urol. (IF 5.9) Pub Date : 2024-09-03 Neal D Shore,Ugo De Giorgi,Stephen J Freedland
-
A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation. J. Urol. (IF 5.9) Pub Date : 2024-09-03 Steven E Canfield,Arvin K George,Joshua S Jue,Sara C Lewis,Matthew S Davenport,Varaha S Tammisetti,Mahir Maruf,Leonardo D Borregalaes,Yara Kadria-Vili,Jon A Schwartz,Jennifer West,Naomi J Halas,Ardeshir R Rastinehad
PURPOSE Focal therapy aims to provide a durable oncologic treatment option for men with prostate cancer (PCa), while preserving their quality of life. Most focal therapy modalities rely on the direct tissue effect, resulting in a possible nontargeted approach to ablation. Here, we report the results of the first human feasibility trial utilizing nanoparticle-directed focal photothermal ablation for
-
Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study. J. Urol. (IF 5.9) Pub Date : 2024-08-30 Jessica DeLong,Ramón Virasoro,Merycarla Pichardo,Rafael Estrella,Ramón Rodríguez Lay,Gustavo Espino,Sean Elliott
PURPOSE We report the 5-year study closeout results for the ROBUST I trial evaluating the safety and efficacy of the Optilume drug-coated balloon (DCB) for men with short, recurrent bulbar urethral strictures. MATERIALS AND METHODS Adult men with recurrent bulbar urethral strictures ≤ 2 cm long and lumen < 12F were included in the study and treated with the Optilume DCB. Outcome measures included symptom
-
Time to Change Our Mindset! Integrating Sustainability Into Urological Practice. J. Urol. (IF 5.9) Pub Date : 2024-08-27 Golena Fernandez Moncaleano,Nadya York,Khurshid R Ghani
-
Diagnostic Pathway Outcomes for Biparametric Magnetic Resonance Imaging-Targeted Lesions Using Cognitive Registration and Freehand Transperineal Prostate Biopsy in Biopsy-Naïve Men (CRAFT Single-Center Study). J. Urol. (IF 5.9) Pub Date : 2024-08-27 Samara Fleville,Carole O'Neill,Daniel Safar,Alex Macleod,Colin Mulholland,Filip Subin
PURPOSE Enhanced histological detection of clinically significant prostate cancer is the goal of the prebiopsy imaging pathway. Risk stratification at a prebiopsy meeting can facilitate optimization of lesion targeting. We aimed to evaluate the feasibility of cognitive registration, freehand transperineal prostate biopsy in a biopsy-naïve population following biparametric MRI for the detection of clinically
-
Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation. J. Urol. (IF 5.9) Pub Date : 2024-08-26 Daniel R Greenberg,Luis C Gago,Sai Kaushik S R Kumar,Evan J Panken,Emily J Ji,Kyle P Tsai,Kian Asanad,Solomon Hayon,Robert E Brannigan,Joshua A Halpern
PURPOSE Epididymal cyst lesions (ECLs) include both spermatoceles and epididymal cysts and are often incidentally found on physical exam or scrotal US (SUS). We aimed to determine the association of ECLs and semen parameters among men presenting for fertility evaluation. MATERIALS AND METHODS We reviewed men at our institution who had at least 1 semen analysis and SUS available for review between 2002
-
Why Did My Paper Take So Long To Review? J. Urol. (IF 5.9) Pub Date : 2024-08-26 George Koch,D Robert Siemens
-
Letter: Complications: The Experience of the Urologic Surgeon. J. Urol. (IF 5.9) Pub Date : 2024-08-22 Kevin B Ginsburg,Mahin Mirza,Khurshid R Ghani,Karla Witzke
-
Impact of SPY Fluorescence Angiography on Incidence of Ureteroenteric Stricture After Urinary Diversion. J. Urol. (IF 5.9) Pub Date : 2024-08-20 Clinton Yeaman,Grace Ignozzi,Aisha Kazeem,Sumit Isharwal,Tracey L Krupski,Stephen H Culp
PURPOSE Ureteroenteric strictures (UESs) are a common and morbid complication of radical cystectomy and urinary diversions. UES occurs in 4% to 25% of all patients undergoing urinary diversion, and anastomotic ischemia is implicated in stricture formation. SPY fluorescence angiography is a technology that can be employed during open surgery that allows for evaluation of ureteral perfusion. MATERIALS
-
Updates to Male Infertility: AUA/ASRM Guideline (2024). J. Urol. (IF 5.9) Pub Date : 2024-08-15 Robert E Brannigan, Linnea Hermanson, Janice Kaczmarek, Sennett K Kim, Erin Kirkby, Cigdem Tanrikut
In 2023 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2020 publication of this Guideline. The resulting 2024 Guideline Amendment addresses updated recommendations to provide guidance on the appropriate evaluation and management of the male partner in an infertile couple.
-
Randomized Controlled Trial of Ultrasonic Propulsion-Facilitated Clearance of Residual Kidney Stone Fragments vs Observation. J. Urol. (IF 5.9) Pub Date : 2024-08-15 Mathew D Sorensen, Barbrina Dunmire, Jeff Thiel, Bryan W Cunitz, Barbara H Burke, Branda J Levchak, Christina Popchoi, Arturo E Holmes, John C Kucewicz, M Kennedy Hall, Manjiri Dighe, Jessica C Dai, Fionnuala C Cormack, Ziyue Liu, Michael R Bailey, Michael P Porter, Jonathan D Harper
Ultrasonic propulsion is an investigational procedure for awake patients. Our purpose was to evaluate whether ultrasonic propulsion to facilitate residual kidney stone fragment clearance reduced relapse.
-
Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. J. Urol. (IF 5.9) Pub Date : 2024-08-14 Lorenzo Storino Ramacciotti,Francesco Cei,Jacob S Hershenhouse,Daniel Mokhtar,Severin Rodler,Karanvir Gill,David Strauss,Luis G Medina,Jie Cai,Andre Luis Abreu,Mihir M Desai,Rene Sotelo,Inderbir S Gill,Giovanni E Cacciamani
PURPOSE This cross-sectional study assessed a generative artificial intelligence platform to automate the creation of accurate, appropriate, and compelling social media (SoMe) posts from urological journal articles. MATERIALS AND METHODS One hundred SoMe posts from the top 3 journals in urology X (formerly Twitter) profiles were collected from August 2022 to October 2023. A freeware generative pre-trained
-
Incontinence After Prostate Treatment: What Does the Future Hold? J. Urol. (IF 5.9) Pub Date : 2024-08-13 Benjamin N Breyer,Alex J Vanni,O Lenaine Westney
-
The US News and World Report Rankings in Pediatric Urology: A Crisis of Trust and a Call for Authenticity. J. Urol. (IF 5.9) Pub Date : 2024-08-12 Benjamin N Abelson,Victoria Maxon,Kathleen Kieran
-
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer. J. Urol. (IF 5.9) Pub Date : 2024-08-09 Neal Shore,Christopher Pieczonka,Sean Heron,Mukaram Gazi,David Cahn,Laurence H Belkoff,Aaron Berger,Brian Mazzarella,Joseph Veys,Charles Idom,David Morris,Gautam Jayram,Alexander Engelman,Paul Dato,Richard Bevan-Thomas,David R Wise,Mary Kay Hardwick,Susan Rojahn,Paige Layman,Brandie Heald,Rachel E Ellsworth,Kathryn E Hatchell,Robert L Nussbaum,Sarah M Nielsen,Edward D Esplin
PURPOSE Identification of pathogenic germline variants in patients with prostate cancer can help inform treatment selection, screening for secondary malignancies, and cascade testing. Limited real-world data are available on clinician recommendations following germline genetic testing in patients with prostate cancer. MATERIALS AND METHODS Patient data and clinician recommendations were collected from
-
The Journal of Urology® Home Study Course 2024 Volume 211/212: Erratum. J. Urol. (IF 5.9) Pub Date : 2024-08-08
-
Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Christopher D Gaffney, Emily A Vertosick, Vincent Laudone, Alvin C Goh, Sigrid V Carlsson, Eugene Pietzak, Timothy Donahue, Robert Smith, Karim Touijer, Andrew J Vickers, Behfar Ehdaie
Incisional hernias are a frequent complication following robotic radical prostatectomy. Observational data in men undergoing robotic prostatectomy suggest that transverse closure resulted in lower hernia rates than vertical closure. We sought to compare the incidence of incisional hernia after robotic radical prostatectomy after vertical and transverse extraction site closure.
-
Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Landon Trost, John Mulhall, Wayne Hellstrom
Our goal was to identify new Peyronie's disease (PD) subtypes, non-PD penile curvature classifications, and define active (acute) vs stable (chronic) phases of disease using evidence-based analyses.
-
Initial Clinical Experience With a Novel Robotically Assisted Platform for Combined Mini-Percutaneous Nephrolithotomy and Flexible Ureteroscopic Lithotripsy. J. Urol. (IF 5.9) Pub Date : 2024-08-08 Jaime Landman, Ralph V Clayman, Andrei D Cumpanas, Roshan M Patel, Pengbo Jiang, Zachary E Tano, Sohrab N Ali, Nancy L Sehgel, Jacob W Caldwell, Chiara Gatti, William J Petraiuolo, Paul T Morris, Mihir M Desai
We sought to evaluate the technical feasibility of performing a combined robotically assisted mini-percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy (URS) procedure by a single urologist using the MONARCH Platform, Urology (Johnson & Johnson MedTech, Redwood City, California).
-
Perineal Urethrostomy for Complex Urethral Strictures: Long-Term Patient-Reported Outcomes from a Reconstructive Referral Center and a Scoping Literature Review. J. Urol. (IF 5.9) Pub Date : 2024-08-02 Jakob Klemm, Roland Dahlem, Robert J Schulz, Daniel R Stelzl, Dejan K Filipas, Christian Brömmer, Shahrokh F Shariat, Margit Fisch, Malte W Vetterlein
There is a paucity of long-term objective and patient-reported outcomes after definitive perineal urethrostomy for complex urethral strictures. Our objective is to determine comprehensive long-term success of perineal urethrostomy with our 15-year experience at a reconstructive referral center.